P. Karhunen and M. Tenhu, Adult polycystic liver and kidney diseases are separate entities, Clin. Genet, vol.30, pp.29-37, 2008.

J. P. Calvet and J. J. Grantham, The genetics and physiology of polycystic kidney disease, Semin. Nephrol, vol.21, pp.107-123, 2001.

J. Ghata and B. D. Cowley, Polycystic Kidney Disease. Compr. Physiol, vol.7, pp.945-975, 2017.

M. Y. Wong, G. W. Mccaughan, and S. I. Strasser, An update on the pathophysiology and management of polycystic liver disease, Expert Rev. Gastroenterol. Hepatol, vol.11, pp.569-581, 2017.

W. R. Cnossen and J. P. Drenth, Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management, Orphanet J. Rare Dis, vol.9, p.69, 2014.

J. R. Martinez and J. J. Grantham, Polycystic kidney disease: Etiology, pathogenesis, and treatment, Dis. Mon, vol.41, pp.693-765, 1995.

M. S. De-miranda-henriques, . De-morais, and E. J. Villar, The Liver and Polycystic Kidney Disease, Polycystic Kidney Disease, 2015.

C. Bergmann, Polycystic kidney disease, Nat. Rev. Dis. Primer, vol.4, p.50, 2018.

R. W. Schrier, Predictors of autosomal dominant polycystic kidney disease progression, J. Am. Soc. Nephrol. JASN, vol.25, pp.2399-2418, 2014.

C. Zhou, Dialysis modality and mortality in polycystic kidney disease: Dialysis modality and mortality in PKD, Hemodial. Int, vol.22, pp.515-523, 2018.

E. M. Spithoven, Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry, Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. -Eur. Ren. Assoc

F. Temmerman, Systematic review: the pathophysiology and management of polycystic liver disease: Systematic review: pathophysiology and management of polycystic liver disease, Aliment. Pharmacol. Ther, vol.34, pp.702-713, 2011.

B. Aussilhou, Treatment of polycystic liver disease, J. Visc. Surg, vol.155, pp.471-481, 2018.

P. A. Gabow, Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease, Hepatology, vol.11, pp.1033-1037, 1990.

J. F. Gigot, Adult polycystic liver disease: is fenestration the most adequate operation for long-term management?, Ann. Surg, vol.225, pp.286-294, 1997.

A. Gong, Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes, Am. J. Physiol.-Cell Physiol, vol.284, pp.1205-1214, 2003.

L. Van-keimpema, Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial, Gastroenterology, vol.137, pp.1661-1668, 2009.

M. C. Hogan, Somatostatin analog therapy for severe polycystic liver disease: results after 2 years, Nephrol. Dial. Transplant, vol.27, pp.3532-3539, 2012.

K. E. Mostov, mTOR is out of control in polycystic kidney disease, Proc. Natl. Acad. Sci, vol.103, pp.5247-5248, 2006.

M. Chrispijn, Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: Results from a randomized controlled trial, J. Hepatol, vol.59, pp.153-159, 2013.

R. Sherstha, Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease, Hepatology, vol.26, pp.1282-1286, 1997.

L. Van-keimpema, D. B. De-koning, S. P. Strijk, and J. P. Drenth, Aspirationsclerotherapy Results in Effective Control of Liver Volume in Patients with Liver Cysts, Dig. Dis. Sci, vol.53, p.2251, 2008.

T. N. Robinson, G. V. Stiegmann, and G. T. Everson, Laparoscopic palliation of polycystic liver disease, Surg. Endosc. Interv. Tech, vol.19, pp.130-132, 2005.

T. M. Gall, G. C. Oniscu, K. Madhavan, R. W. Parks, and O. J. Garden, Surgical management and longterm follow-up of non-parasitic hepatic cysts, HPB, vol.11, pp.235-241, 2009.

M. Kabbej, A. Sauvanet, D. Chauveau, O. Farges, and J. Belghiti, Laparoscopic fenestration in polycystic liver disease, BJS, vol.83, pp.1697-1701, 1996.

R. T. Russell, Surgical management of polycystic liver disease, World J. Gastroenterol, vol.13, p.5052, 2007.

T. J. Gevers and J. P. Drenth, Diagnosis and management of polycystic liver disease, Nat. Rev. Gastroenterol. Hepatol, vol.10, pp.101-108, 2013.

H. L. Arnold and S. A. Harrison, New Advances in Evaluation and Management of Patients with Polycystic Liver Disease, Am. J. Gastroenterol, vol.100, pp.2569-2582, 2005.

B. Aussilhou, Extended Liver Resection for Polycystic Liver Disease Can Challenge Liver Transplantation, Ann. Surg, vol.252, pp.735-743, 2010.

F. T. Chebib, Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease, J. Am. Coll. Surg, vol.223, 2016.

Y. Ubara, Intravascular embolization therapy in a patient with an enlarged polycystic liver, Am. J. Kidney Dis, vol.43, pp.733-738, 2004.

R. Takei, Percutaneous Transcatheter Hepatic Artery Embolization for Liver Cysts in Autosomal Dominant Polycystic Kidney Disease, Am. J. Kidney Dis, vol.49, pp.744-752, 2007.

H. C. Park, Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients, J. Korean Med. Sci, vol.24, pp.57-61, 2009.

T. E. Starzl, Liver Transplantation for Polycystic Liver Disease, Arch. Surg, vol.125, pp.575-577, 1990.

J. T. Baber, J. R. Hiatt, R. W. Busuttil, and V. G. Agopian, A 20-Year Experience with Liver Transplantation for Polycystic Liver Disease: Does Previous Palliative Surgical Intervention Affect Outcomes?, J. Am. Coll. Surg, vol.219, pp.695-703, 2014.

N. Chandok, J. Uhanova, and P. Marotta, Clinical outcomes of liver transplantation for polycystic liver disease: A single center experience, Ann. Hepatol, vol.9, pp.278-281, 2010.

B. Taner, Polycystic liver disease and liver transplantation: single-institution experience, Transplant. Proc, vol.41, pp.3769-3771, 2009.

A. Rasmussen, H. F. Davies, N. V. Jamieson, D. B. Evans, and R. Y. Calne, Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival, Transplantation, vol.59, pp.919-921, 1995.

C. Coquillard, Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset, Liver Int. Off. J. Int. Assoc. Study Liver, vol.36, pp.1018-1025, 2016.

C. Shen, Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease, Am. J. Kidney Dis. Off. J. Natl. Kidney Found, vol.69, pp.482-484, 2017.

P. A. Clavien, The Clavien-Dindo classification of surgical complications: five-year experience, Ann. Surg, vol.250, pp.187-196, 2009.

N. M. Jasiak and J. M. Park, Immunosuppression in Solid-Organ Transplantation: Essentials and Practical Tips, Crit. Care Nurs. Q, vol.39, pp.227-240, 2016.

M. A. Lim, J. Kohli, and R. D. Bloom, Immunosuppression for kidney transplantation: Where are we now and where are we going?, Transplant. Rev. Orlando Fla, vol.31, pp.10-17, 2017.

J. Levitsky and S. Feng, Tolerance in clinical liver transplantation, Hum. Immunol, vol.79, pp.283-287, 2018.

T. Ueno, Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome, Transplantation, vol.82, pp.501-507, 2006.

K. Swenson, Liver transplantation for adult polycystic liver disease, Hepatol. Baltim. Md, vol.28, pp.412-415, 1998.

L. S. Yang, L. L. Shan, A. Saxena, and D. L. Morris, Liver transplantation: a systematic review of long-term quality of life, Liver Int, vol.34, pp.1298-1313, 2014.

A. T. Song, Liver transplantation: Fifty years of experience, World J. Gastroenterol, vol.20, p.5363, 2014.

T. Y. Ll and O. , Highly symptomatic adult polycystic liver disease: options and results of surgical management, p.9, 2019.

N. Kanaan, O. Devuyst, and Y. Pirson, Renal transplantation in autosomal dominant polycystic kidney disease, Nat. Rev. Nephrol, vol.10, pp.455-465, 2014.

R. Ruiz, Long-term Analysis of Combined Liver and Kidney Transplantation at a Single Center, Arch. Surg, vol.141, pp.735-742, 2006.

C. Coquillard, Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset, Liver Int. Off. J. Int. Assoc. Study Liver, vol.36, pp.1018-1025, 2016.

E. Dumontet, Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients, Liver Int, vol.36, pp.401-409, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01187428

C. Creput, Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation, Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg, vol.3, pp.348-356, 2003.

G. Demirci, Results of combined and sequential liver-kidney transplantation, Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc, vol.9, pp.1067-1078, 2003.

R. Ruiz, Long-term analysis of combined liver and kidney transplantation at a single center, Arch. Surg. Chic. Ill, vol.discussion, pp.741-742, 2006.

Y. Kurata, Clinical relevance of post-transplant pharmacodynamic analysis of cyclosporine in renal transplantation, Int. Immunopharmacol, vol.22, pp.384-391, 2014.

M. Yee and H. Tan, Use of everolimus in liver transplantation, World J. Hepatol, vol.9, pp.990-1000, 2017.

H. Abe and K. Mafune, Risk factors for maintenance hemodialysis patients undergoing elective and emergency abdominal surgery, Surg. Today, vol.44, pp.1906-1911, 2014.

T. Ito, Risk factors for postoperative complications in patients on maintenance hemodialysis who undergo abdominal surgery, Asian J. Surg, vol.39, pp.211-217, 2016.

R. B. Freeman, Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula, Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc, vol.12, pp.128-136, 2006.

L. Arrazola, D. Moonka, R. G. Gish, and G. T. Everson, Model for end-stage liver disease (MELD) exception for polycystic liver disease, Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc, vol.12, pp.110-111, 2006.

F. Stickel, D. Inderbitzin, and D. Candinas, Role of nutrition in liver transplantation for end-stage chronic liver disease, Nutr. Rev, vol.66, pp.47-54, 2008.

N. Halliday and R. H. Westbrook, Liver transplantation: post-transplant management, Br. J. Hosp. Med. Lond. Engl, vol.78, pp.278-285, 2005.

E. K. Geissler, Post-transplantation malignancies: here today, gone tomorrow?, Nat. Rev. Clin. Oncol, vol.12, pp.705-717, 2015.

A. Gutierrez-dalmau and J. M. Campistol, Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review, Drugs, vol.67, pp.1167-1198, 2007.

H. Engberg, Cancer risk and mortality after kidney transplantation: a populationbased study on differences between Danish centres using standard immunosuppression with and without glucocorticoids, Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. -Eur. Ren. Assoc, vol.31, pp.2149-2156, 2016.

C. Carenco, S. Faure, J. Ursic-bedoya, A. Herrero, and G. P. Pageaux, Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management, World J. Gastroenterol, vol.22, pp.427-434, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01881998

S. Lichtenberg, The incidence of post-transplant cancer among kidney transplant recipients is associated with the level of tacrolimus exposure during the first year after transplantation, Eur. J. Clin. Pharmacol, vol.73, pp.819-826, 2017.